Emergence of CMY-2- and DHA-1-typeAmpC β-lactamases in Entero- bacter cloacae isolated from several hospitals of Qazvin and Tehran, Iran
,
Abstract
Background and Objectives: The emergence of plasmid-mediated AmpC (pAmpC) β-lactamases conferring resistance to third-generation cephalosporins has become a major clinical concern worldwide. The aims of this study were to determine the prevalence of pAmpC-producing E. cloacae isolates and typing of them in Qazvin and Tehran provinces, Iran.
Materials and Methods: A total of 120 cefoxitin non-susceptible isolates of E. cloacae were obtained from educational hospitals of Qazvin and Tehran, Iran. Bacterial identification was performed by standard laboratory methods and API 20E strips. Susceptibility to cefoxitin was determined by Kirby-Bauer disk diffusion method. PCR and sequencing were employed to detect pAmpC families’ genes (ACC, FOX, MOX, DHA, CIT and EBC) and the clonal relatedness of pAmpC-positive isolates was evaluated by enterobacterial repetitive intergenic consensus (ERIC)-PCR method.
Results: In total, 20 (16.7%) isolates of E. cloacae were positive for presence of pAmpC genes among those blaDHA-1 (14.2%) was the most common gene followed by blaCMY-2 (2.5%). Results of ERIC-PCR showed that that the prevalence of DHA-1 and CMY-2-producing E. cloacae isolates was not due to clonal outbreaks.
Conclusion: In present study, we showed the first emergence of DHA-1 and CMY-2 types of pAmpC-producing E. cloacae isolates in Iran. The appearance of pAmpC should be considered as a warning for the implementation of appropriate infection control and therapeutic policies in order to prevent the dissemination of these resistant organisms in our hospital settings.
Glatz K, Tóth A, Pászti J. The cyclohexane tolerance and Phe-Arg-β-naphtylamide susceptibility of multi- drug-resistant Enterobacter cloacae clinical isolates,and the predominance of one PFGE clone in Hungary.
Clin Microbiol Infect 2011; 17: 1254-1261.
Lee CC, Lee NY, Yan JJ, Lee HC, Chen PL, Chang CM, et al. Bacteremia due to extended-spectrum-be- ta-lactamase-producing Enterobacter cloacae: role of carbapenem therapy. Antimicrob Agents Chemother 2010; 54: 3551-3556.
Pallett A, Hand K. Complicated urinary tract infec- tions: practical solutions for the treatment of multiresis- tant Gram-negative bacteria. J Antimicrob Chemother
; 65 Suppl 3: iii25-33.
Rawat D, Nair D. Extended-spectrum beta-lactamases in Gram Negative Bacteria. J Glob Infect Dis 2010; 2:263-274.
Bradford PA. Extended-spectrum beta-lactamases in the 21st century: characterization, epidemiology, and detection of this important resistance threat. Clin Mi- crobiol Rev 2001; 14: 933-951.
Peymani A, Farivar TN, Sanikhani R, Javadi A, Na- jafipour R. Emergence of TEM, SHV, and CTX-M-Ex- tended Spectrum β-lactamases and class 1 integron among Enterobacter cloacae isolates collected from hospitals of Tehran and Qazvin, Iran. Microb Drug Re- sist 2014; 20: 424-430.
Philippon A, Arlet G, Jacoby GA. Plasmid-determined AmpC-type beta-lactamases. Antimicrob Agents Chemother 2002; 46: 1-11.
Mohamudha PR, Harish BN, Parija SC. Molecular de- scription of plasmid-mediated AmpC beta-lactamases among nosocomial isolates of Escherichia coli & Kleb- siella pneumoniae from six different hospitals in India. Indian J Med Res 2012; 135: 114-119.
Campana EH, Barbosa PP, Fehlberg LCC, Gales AC.
Frequency of plasmid-mediated AmpC in Enterobacte- riaceae isolated in a Brazilian teaching hospital. Braz J Microbiol 2013; 44: 477-480.
Nevine Fam DG, Manal El Said, Inas El Defrawy, Ehab El Dadei, Soheir El Attar, Ashraf Sorur, et al. Preva- lence of Plasmid-Mediated ampC Genes in Clinical Isolates of Enterobacteriaceae from Cairo, Egypt. Br Microbiol Res J 2013; 3: 525–537.
Jacoby GA. AmpC β-lactamases. Clin Microbiol Rev
; 22: 161-182.
Drawz SM, Bonomo RA. Three decades of β-lactamase
inhibitors. Clin Microbiol Rev 2010; 23: 160-201.
Paterson DL, Bonomo RA. Extended-spectrum β-lact- amases: a clinical update. Clin Microbiol Rev 2005; 18:
-686.
Mohanty S, Singhal R, Sood S, Dhawan B, Das BK, Ka- pil A. Comparative in vitro activity of β-lactam/β-lac- tamase inhibitor combinations against Gram negative bacteria. Indian J Med Res 2005; 122: 425-428.
Perez-Perez FJ, Hanson ND. Detection of plasmid-me- diated AmpC β-lactamase genes in clinical isolates by
using multiplex PCR. J Clin Microbiol 2002; 40: 2153-
Verdet C, Benzerara Y, Gautier V, Adam O, Ould-Ho- cine Z, Arlet G. Emergence of DHA-1-producing Kleb- siella spp. in the Parisian region: genetic organization of the ampC and ampR genes originating from Mor- ganella morganii. Antimicrob Agents Chemother 2006;50: 607-617.
Helmy MM, Wasfi R. Phenotypic and molecular char- acterization of plasmid mediated AmpC β-Lactamases among Escherichia coli, Klebsiella spp., and Prote- us mirabilis isolated from urinary tract infections in Egyptian hospitals. Biomed Res Int 2014; 2014: 171548.
Clinical and Laboratory Standards Institute (CLSI).
Performance standards for antimicrobial suscepti- bility testing: seventeenth informational supplement M100-S23, 2013 USA: Wayne, PA.
Smith JL, Drum DJ, Dai Y, Kim JM, Sanchez S, Maur- er JJ, et al. Impact of antimicrobial usage on antimicro- bial resistance in commensal Escherichia coli strains colonizing broiler chickens. Appl Environ Microbiol 2007; 73: 1404-1414.
Mansouri S, Kalantar Neyestanaki D, Shokoohi M, Halimi S, Beigverdi R, Rezagholezadeh F, et al. Char- acterization of AmpC, CTX-M and MBLs types of β-lactamases in clinical isolates of Klebsiella pneumo- niae and Escherichia coli producing extended spec- trum β-lactamases in Kerman, Iran. Jundishapur J Microbiol 2014; 7: e8756.
Wang R, Wu S, Li X, He P, Liu Y. Detection of AmpC β-lactamase and drug resistance of Enterobacter cloa- cae. Front Med China 2009; 3: 72-75.
Yusuf I, Haruna M. Detection of AMPC and ESBL Pro- ducers among Enterobacteriaceae in a Tertiary Health Care in, Kano- Nigeria. Int J Sci Tech 2013; 3: 220-225.
Yamasaki K, Komatsu M, Abe N, Fukuda S, Miyamoto Y, Higuchi T, et al. Laboratory surveillance for pro- spective plasmid-mediated AmpC beta-lactamases in the Kinki region of Japan. J Clin Microbiol 2010; 48:3267-3273.
Li Y, Li Q, Du Y, Jiang X, Tang J, Wang J, et al. Prev- alence of plasmid-mediated AmpC beta-lactamases in a Chinese university hospital from 2003 to 2005: first report of CMY-2-Type AmpC β-lactamase resistance in China. J Clin Microbiol 2008; 46: 1317-1321.
Yilmaz NO, Agus N, Bozcal E, Oner O, Uzel A. Detec- tion of plasmid-mediated AmpC β-lactamase in Esch- erichia coli and Klebsiella pneumoniae. Indian J Med Microbiol 2013; 31: 53-59.
Tan TY, Ng LS, He J, Koh TH, Hsu LY. Evaluation of screening methods to detect plasmid-mediated AmpC in Escherichia coli, Klebsiella pneumoniae, and Prote- us mirabilis. Antimicrob Agents Chemother 2009; 53:146-149.
Kaneko K, Okamoto R, Nakano R, Kawakami S, Inoue M. Gene mutations responsible for overexpression of AmpC β-lactamase in some clinical isolates of Entero- bacter cloacae. J Clin Microbiol 2005; 43: 2955-2958.
Seeberg AH, Tolxdorff-Neutzling RM, Wiedemann B.
Chromosomal β-lactamases of Enterobacter cloacae are responsible for resistance to third-generation ceph- alosporins. Antimicrobial Agents and Chemotherapy
; 23: 918-925.
Tajbakhsh M, García Migura L, Rahbar M, Svendsen CA, Mohammadzadeh M, Zali MR, et al. Antimicro- bial-resistant Shigella infections from Iran: an over- looked problem? J Antimicrob Chemother 2012; 67:1128-1133.
Mata C, Miró E, Alvarado A, Garcillán-Barcia MP, Toleman M, Walsh TR, et al. Plasmid typing and ge- netic context of AmpC β-lactamases in Enterobacteria- ceae lacking inducible chromosomal ampC genes: find- ings from a Spanish hospital 1999–2007. J Antimicrob Chemother 2012; 67: 115-122.
Song W, Kim JS, Kim HS, Yong D, Jeong SH, Park MJ, et al. Increasing trend in the prevalence of plasmid-me- diated AmpC beta-lactamases in Enterobacteriaceae lacking chromosomal ampC gene at a Korean universi- ty hospital from 2002 to 2004. Diagn Microbiol Infect Dis 2006; 55: 219-224.
| Files | ||
| Issue | Vol 8 No 3 (2016) | |
| Section | Articles | |
| Keywords | ||
| Enterobacter cloacae PAmpC ERIC-PCR | ||
| Rights and permissions | |
|
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |
